infrastructure > manufacturing
Fermentation & Downstream for Diptheria
Biological E. Limited has several firsts to its credit. It was the first private sector biological products company in India; the first pharmaceutical company to manufacture anti-TB drugs in India and the first private sector vaccine manufacturer in the country. However, Biological E Limited's standing and reputation lie not in merely being first but in its long standing and firm commitment to maintaining the highest quality standards through constant innovation, partnerships with reputed institutes and modernization of its manufacturing facilities.

Instrument Lab
Biological E Limited is investing approximately US $ 50 Million towards the development and expansion of infrastructure. State-of-the-art equipment is being installed in all locations that will meet the US FDA and European MEA standards in manufacturing, quality control and pre-clinical activities. As per the regulatory requirements we have specialized suites for different manufacturing activities. Dedicated laboratories have also been provided to carry out testing of the quality control setup.

Several projects are underway to strengthen and expand Biological E Limited's drive to internationalize its business. One of these is the compact and well-maintained production facility to manufacture APIs in Pattancheru, which has ample scope for future expansion.

Vial Filling Machine
Another project underway is the modern Biotech facility, with an investment of Rs. 100 crores, in the Genome Valley, Andhra Pradesh. We have taken up this state-of-the-art Technology project to produce a new generation of vaccines, focused on reaching out to international markets. This project complies strictly with the WHO and US FDA Good Manufacturing Practices guidelines.